TY - JOUR
T1 - Implementation of the recommendations for RBC transfusions for critically ill children from the pediatric critical care transfusion and Anemia expertise initiative
AU - Steffen, Katherine M.
AU - Bateman, Scot T.
AU - Valentine, Stacey L.
AU - Small, Sara
AU - Spinella, Philip C.
AU - Doctor, Allan
N1 - Funding Information:
1Division of Pediatric Critical Care Medicine, Department of Pediatrics, Lucile Packard Children’s Hospital, Stanford University School of Medicine, Palo Alto, CA. 2Division of Pediatric Critical Care, Department of Pediatrics, University of Massachusetts Medical School, Worcester, MA. 3Division of Pediatric Critical Care Medicine, Department of Pediatrics, St. Louis Children’s Hospital, Washington University School of Medicine in St. Louis, St. Louis, MO. Pediatric Critical Care Transfusion and Anemia Expertise Initiative (TAXI) members are listed in Appendix 1. The Transfusion and Anemia Expertise Initiative was supported, in part, by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute under award number 1 R13 HD088086-01, the Society for the Advancement of Blood Management (SABM)-Haemonetics Research Starter Grant, the CHU-Sainte-Justine Foundation, the Washington University Children’s Discovery Institute (CDI-E1-2015–499), and the University of Massachusetts Medical School. Dr. Bateman’s institution received funding from the National Institutes of Health (NIH) R13 from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Heart, Lung, and Blood Institute (NHLBI) and the Society for the Advancement of Blood Management (SABM). Drs. Bateman and Doctor received support for article research from the NIH. Dr. Valentine’s institution received funding from NICHD and NHLBI under award number 1 R13 HD088086-01; the SABM SABM-Haemonetics Research Starter Grant; and Washington University Children’s Discovery Institute (CDI-E1-2015–499). She received other support from CHU-Sainte-Justine Foundation and the University of Massachusetts Medical School, and she received support for article research from the NIH, the SABM SABM-Haemonetics Research Starter Grant, CHU-Sainte-Justine Foundation, Washington University Children’s Discovery Institute, and the University of Massachusetts Medical School. Dr. Small’s institution received funding from Washington University in St. Louis. Dr. Spinella received funding from New Health Sciences. Dr. Doctor’s institution received funding from the NIH, the Department of Defense, and Kalocyte, Inc. Dr. Steffen has disclosed that she does not have any potential conflicts of interest. Address requests for reprints to: Katherine Steffen, MD, MHS, Division of Pediatric Critical Care Medicine, Department of Pediatrics, Stanford University, 770 Welch Road, Suite 435, Palo Alto, CA 94304. E-mail: steffen3@stanford.edu
Funding Information:
The Transfusion and Anemia Expertise Initiative was supported, in part, by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Heart, Lung, and Blood Institute under award number 1 R13 HD088086-01, the Society for the Advancement of Blood Management (SABM)-Haemonetics Research Starter Grant, the CHU-Sainte-Justine Foundation, the Washington University Children's Discovery Institute (CDI-E1-2015-499), and the University of Massachusetts Medical School. Dr. Bateman's institution received funding from the National Institutes of Health (NIH) R13 from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Heart, Lung, and Blood Institute (NHLBI) and the Society for the Advancement of Blood Management (SABM). Drs. Bateman and Doctor received support for article research from the NIH. Dr. Valentine's institution received funding from NICHD and NHLBI under award number 1 R13 HD088086-01; the SABM SABM-Haemonetics Research Starter Grant; and Washington University Children's Discovery Institute (CDI-E1-2015-499). She received other support from CHU-Sainte-Justine Foundation and the University of Massachusetts Medical School, and she received support for article research from the NIH, the SABM SABM-Haemonetics Research Starter Grant, CHU-Sainte-Justine Foundation, Washington University Children's Discovery Institute, and the University of Massachusetts Medical School. Dr. Small's institution received funding from Washington University in St. Louis. Dr. Spinella received funding from New Health Sciences. Dr. Doctor's institution received funding from the NIH, the Department of Defense, and Kalocyte, Inc. Dr. Steffen has disclosed that she does not have any potential conflicts of interest.
Publisher Copyright:
Copyright © 2018 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
PY - 2018
Y1 - 2018
N2 - Objectives: To provide context for the implementation of the Pediatric Critical Care Transfusion and Anemia Expertise Initiative recommendations for RBC transfusions including a review of prior research related to implementation of transfusion guidelines, efforts to facilitate implementation through Transfusion and Anemia Expertise Initiative, and to provide a framework for recommendation implementation. Design: Review of existing clinical literature and description of a comprehensive approach to implementation based on Implementation Science principles. Results: The Transfusion and Anemia Expertise Initiative recommendations on RBC transfusions are based on clinical evidence and aim to limit unnecessary and potentially harmful transfusions. Prior efforts to use transfusion guidelines include use of provider education, local guidelines, visual aids, prospective and retrospective audit and feedback as well as computerized decision support tools; however, no single approach has been identified as optimal for implementation in pediatric critical care settings. Evidence around provider beliefs and transfusion decision-making point to the need for additional provider education, emphasizing the importance of limiting transfusions, and the development of recommendations, such as the Transfusion and Anemia Expertise Initiative guidelines, that can be applied to specific clinical conditions. Conclusions: The Transfusion and Anemia Expertise Initiative guidelines will be broadly disseminated; however, coordinated implementation efforts will be required to impact practice. An approach that encourages involvement of a wide range of multiprofessional stakeholders, formal agreement on the implemented guidelines, selection of strategies that are practical and feasible, and active monitoring of clinical practice and outcomes throughout implementation is recommended. A formal second stage Transfusion and Anemia Expertise Initiative - Continuous Assessment of Blood-use is proposed to enhance implementation of the recommendations, follow uptake and impact on practice and patient outcomes, and ensure integration of new clinical evidence into the existing guideline as it is developed.
AB - Objectives: To provide context for the implementation of the Pediatric Critical Care Transfusion and Anemia Expertise Initiative recommendations for RBC transfusions including a review of prior research related to implementation of transfusion guidelines, efforts to facilitate implementation through Transfusion and Anemia Expertise Initiative, and to provide a framework for recommendation implementation. Design: Review of existing clinical literature and description of a comprehensive approach to implementation based on Implementation Science principles. Results: The Transfusion and Anemia Expertise Initiative recommendations on RBC transfusions are based on clinical evidence and aim to limit unnecessary and potentially harmful transfusions. Prior efforts to use transfusion guidelines include use of provider education, local guidelines, visual aids, prospective and retrospective audit and feedback as well as computerized decision support tools; however, no single approach has been identified as optimal for implementation in pediatric critical care settings. Evidence around provider beliefs and transfusion decision-making point to the need for additional provider education, emphasizing the importance of limiting transfusions, and the development of recommendations, such as the Transfusion and Anemia Expertise Initiative guidelines, that can be applied to specific clinical conditions. Conclusions: The Transfusion and Anemia Expertise Initiative guidelines will be broadly disseminated; however, coordinated implementation efforts will be required to impact practice. An approach that encourages involvement of a wide range of multiprofessional stakeholders, formal agreement on the implemented guidelines, selection of strategies that are practical and feasible, and active monitoring of clinical practice and outcomes throughout implementation is recommended. A formal second stage Transfusion and Anemia Expertise Initiative - Continuous Assessment of Blood-use is proposed to enhance implementation of the recommendations, follow uptake and impact on practice and patient outcomes, and ensure integration of new clinical evidence into the existing guideline as it is developed.
KW - Critical care
KW - Evidence-based practice
KW - Pediatric
KW - Practice guideline
KW - Red blood cell
KW - Transfusion
UR - http://www.scopus.com/inward/record.url?scp=85054891589&partnerID=8YFLogxK
U2 - 10.1097/PCC.0000000000001592
DO - 10.1097/PCC.0000000000001592
M3 - Article
C2 - 30161073
AN - SCOPUS:85054891589
SN - 1529-7535
VL - 19
SP - S170-S176
JO - Pediatric Critical Care Medicine
JF - Pediatric Critical Care Medicine
IS - 9
ER -